Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances.
Voelzke
Bryan B
BB
Department of Urology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Sakamoto
Kyoko
K
Hantel
Alexander
A
Paner
Gladell P
GP
Kash
Joseph
J
Waters
W Bedford
WB
Campbell
Steven C
SC
D000951:Antigens, Neoplasm / Q000032:analysis; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides; D002292:Carcinoma, Renal Cell / Q000139:chemically induced / Q000188:drug therapy* / Q000556:secondary; D005770:Gastrointestinal Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D007680:Kidney Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000556:secondary; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000556:secondary; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D012509:Sarcoma / Q000737:chemistry / Q000188:drug therapy* / Q000556:secondary*
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit